The clinical physiology of side effects in long-term L-DOPA therapy.
D000109:Acetylcholine / Q000378:metabolism; D001479:Basal Ganglia / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D001933:Brain Stem / Q000378:metabolism; D003404:Creatinine / Q000652:urine; D003937:Diagnosis, Differential; D004298:Dopamine / Q000032:analysis / Q000494:pharmacology / Q000652:urine; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D007980:Levodopa / Q000009:adverse effects*; D009069:Movement Disorders / Q000139:chemically induced / Q000175:diagnosis; D009638:Norepinephrine / Q000652:urine; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000652:urine; D011188:Potassium / Q000652:urine; D011955:Receptors, Drug; D012701:Serotonin / Q000032:analysis / Q000378:metabolism; D012964:Sodium / Q000652:urine; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D011955:Receptors, Drug; D012701:Serotonin; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D012964:Sodium; D003404:Creatinine; D000109:Acetylcholine; D011188:Potassium; D004298:Dopamine; D009638:Norepinephrine